Literature DB >> 30683719

Peptidic degron for IMiD-induced degradation of heterologous proteins.

Vidyasagar Koduri1, Samuel K McBrayer1, Ella Liberzon1, Adam C Wang1, Kimberly J Briggs1, Hyejin Cho1, William G Kaelin2,3.   

Abstract

Current systems for modulating the abundance of proteins of interest in living cells are powerful tools for studying protein function but differ in terms of their complexity and ease of use. Moreover, no one system is ideal for all applications, and the best system for a given protein of interest must often be determined empirically. The thalidomide-like molecules (collectively called the IMiDs) bind to the ubiquitously expressed cereblon ubiquitin ligase complex and alter its substrate specificity such that it targets the IKZF1 and IKZF3 lymphocyte transcription factors for destruction. Here, we mapped the minimal IMiD-responsive IKZF3 degron and show that this peptidic degron can be used to target heterologous proteins for destruction with IMiDs in a time- and dose-dependent manner in cultured cells grown ex vivo or in vivo.

Entities:  

Keywords:  proteasome; protein stability; thalidomide; tunable proteins; ubiquitylation

Mesh:

Substances:

Year:  2019        PMID: 30683719      PMCID: PMC6377458          DOI: 10.1073/pnas.1818109116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Methods: A small-molecule SMASh hit.

Authors:  Jeffrey Hannah; Pengbo Zhou
Journal:  Nat Chem Biol       Date:  2015-09       Impact factor: 15.040

2.  Targeting protein stability with a small molecule.

Authors:  Michael A Lampson; Tarun M Kapoor
Journal:  Cell       Date:  2006-09-08       Impact factor: 41.582

Review 3.  Chemical biology strategies for posttranslational control of protein function.

Authors:  Rishi Rakhit; Raul Navarro; Thomas J Wandless
Journal:  Chem Biol       Date:  2014-09-18

4.  A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules.

Authors:  Laura A Banaszynski; Ling-Chun Chen; Lystranne A Maynard-Smith; A G Lisa Ooi; Thomas J Wandless
Journal:  Cell       Date:  2006-09-08       Impact factor: 41.582

5.  A general chemical method to regulate protein stability in the mammalian central nervous system.

Authors:  Mari Iwamoto; Tomas Björklund; Cecilia Lundberg; Deniz Kirik; Thomas J Wandless
Journal:  Chem Biol       Date:  2010-09-24

6.  Selective degradation of splicing factor CAPERα by anticancer sulfonamides.

Authors:  Taisuke Uehara; Yukinori Minoshima; Koji Sagane; Naoko Hata Sugi; Kaoru Ogawa Mitsuhashi; Noboru Yamamoto; Hiroshi Kamiyama; Kentaro Takahashi; Yoshihiko Kotake; Mai Uesugi; Akira Yokoi; Atsushi Inoue; Taku Yoshida; Miyuki Mabuchi; Akito Tanaka; Takashi Owa
Journal:  Nat Chem Biol       Date:  2017-04-24       Impact factor: 15.040

7.  Global protein stability profiling in mammalian cells.

Authors:  Hsueh-Chi Sherry Yen; Qikai Xu; Danny M Chou; Zhenming Zhao; Stephen J Elledge
Journal:  Science       Date:  2008-11-07       Impact factor: 47.728

8.  Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide.

Authors:  Eric S Fischer; Kerstin Böhm; John R Lydeard; Haidi Yang; Michael B Stadler; Simone Cavadini; Jane Nagel; Fabrizio Serluca; Vincent Acker; Gondichatnahalli M Lingaraju; Ritesh B Tichkule; Michael Schebesta; William C Forrester; Markus Schirle; Ulrich Hassiepen; Johannes Ottl; Marc Hild; Rohan E J Beckwith; J Wade Harper; Jeremy L Jenkins; Nicolas H Thomä
Journal:  Nature       Date:  2014-07-16       Impact factor: 49.962

9.  Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome.

Authors:  Katherine A Donovan; Jian An; Radosław P Nowak; Jingting C Yuan; Emma C Fink; Bethany C Berry; Benjamin L Ebert; Eric S Fischer
Journal:  Elife       Date:  2018-08-01       Impact factor: 8.140

10.  Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4(CRBN.).

Authors:  Anita K Gandhi; Jian Kang; Courtney G Havens; Thomas Conklin; Yuhong Ning; Lei Wu; Takumi Ito; Hideki Ando; Michelle F Waldman; Anjan Thakurta; Anke Klippel; Hiroshi Handa; Thomas O Daniel; Peter H Schafer; Rajesh Chopra
Journal:  Br J Haematol       Date:  2013-12-13       Impact factor: 6.998

View more
  13 in total

1.  A degron system targeting endogenous PD-1 inhibits the growth of tumor cells in mice.

Authors:  Chie Naruse; Kazushi Sugihara; Tatsuhiko Miyazaki; Xuchi Pan; Fumihiro Sugiyama; Masahide Asano
Journal:  NAR Cancer       Date:  2022-06-17

Review 2.  Proteolysis Targeting Chimeras (PROTACs): A Perspective on Integral Membrane Protein Degradation.

Authors:  Camilla Ruffilli; Sascha Roth; Monica Rodrigo; Helen Boyd; Noam Zelcer; Kevin Moreau
Journal:  ACS Pharmacol Transl Sci       Date:  2022-09-05

Review 3.  Targeted protein degradation as a powerful research tool in basic biology and drug target discovery.

Authors:  Tao Wu; Hojong Yoon; Yuan Xiong; Sarah E Dixon-Clarke; Radosław P Nowak; Eric S Fischer
Journal:  Nat Struct Mol Biol       Date:  2020-06-15       Impact factor: 15.369

Review 4.  Cancer therapies based on targeted protein degradation - lessons learned with lenalidomide.

Authors:  Max Jan; Adam S Sperling; Benjamin L Ebert
Journal:  Nat Rev Clin Oncol       Date:  2021-03-02       Impact factor: 66.675

Review 5.  Protein Engineering in the Ubiquitin System: Tools for Discovery and Beyond.

Authors:  Bo Zhao; Yien Che Tsai; Bo Jin; Bufan Wang; Yiyang Wang; Han Zhou; Tomaya Carpenter; Allan M Weissman; Jun Yin
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

6.  NEDD8 nucleates a multivalent cullin-RING-UBE2D ubiquitin ligation assembly.

Authors:  Kheewoong Baek; David T Krist; J Rajan Prabu; Spencer Hill; Maren Klügel; Lisa-Marie Neumaier; Susanne von Gronau; Gary Kleiger; Brenda A Schulman
Journal:  Nature       Date:  2020-02-12       Impact factor: 49.962

7.  Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules.

Authors:  Behnam Nabet; Fleur M Ferguson; Bo Kyung A Seong; Miljan Kuljanin; Alan L Leggett; Mikaela L Mohardt; Amanda Robichaud; Amy S Conway; Dennis L Buckley; Joseph D Mancias; James E Bradner; Kimberly Stegmaier; Nathanael S Gray
Journal:  Nat Commun       Date:  2020-09-18       Impact factor: 14.919

8.  An IMiD-induced SALL4 degron system for selective degradation of target proteins.

Authors:  Satoshi Yamanaka; Yuki Shoya; Saya Matsuoka; Hisayo Nishida-Fukuda; Norio Shibata; Tatsuya Sawasaki
Journal:  Commun Biol       Date:  2020-09-18

Review 9.  The role of small molecules in cell and gene therapy.

Authors:  Lewis L Brayshaw; Carlos Martinez-Fleites; Takis Athanasopoulos; Thomas Southgate; Laurent Jespers; Christopher Herring
Journal:  RSC Med Chem       Date:  2020-12-24

Review 10.  Controlling CRISPR with small molecule regulation for somatic cell genome editing.

Authors:  Namita Khajanchi; Krishanu Saha
Journal:  Mol Ther       Date:  2021-06-24       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.